Smith & Nephew plc (NYSE:SNN) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC grew its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 31.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,975 shares of the medical equipment provider’s stock after purchasing an additional 718 shares during the period. GAMMA Investing LLC’s holdings in Smith & Nephew were worth $73,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of SNN. Brandes Investment Partners LP raised its stake in Smith & Nephew by 20.5% during the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock worth $34,002,000 after acquiring an additional 233,293 shares during the period. River Road Asset Management LLC acquired a new stake in shares of Smith & Nephew during the 3rd quarter worth approximately $38,588,000. Bank of Montreal Can lifted its holdings in shares of Smith & Nephew by 355.8% in the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after purchasing an additional 964,762 shares during the last quarter. Hsbc Holdings PLC boosted its position in Smith & Nephew by 18.9% during the 2nd quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock valued at $13,607,000 after purchasing an additional 87,360 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after buying an additional 193,046 shares during the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. StockNews.com cut Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th. Finally, Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th.

Smith & Nephew Stock Performance

SNN stock opened at $23.97 on Friday. The company has a 50-day simple moving average of $25.00 and a 200 day simple moving average of $27.77. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $10.48 billion, a P/E ratio of 12.23, a PEG ratio of 1.41 and a beta of 0.84. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.